Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Contemp Clin Trials. 2018 May 12;70:24–34. doi: 10.1016/j.cct.2018.05.005

Table 2.

Feasibility. Participants transmitted their BP on average 89% of the days under monitoring and 92% of participants transmitted their BP for more than half the monitored days.

Total N = 26 Days Transmitted Participants N (%)

90 day monitoring N = 19 80–90 12 (63)
70–79* 3 (16)
60–69 1 (5)
50–59 1 (5)
< 50 2 (11)

Extended monitoring N=7 Transmitted daily until HTN controlled or it was felt that control could not be achieved and participant was referred back into primary care 5 (71)
Monitored for 103, 107**, 113,115, 121 days 2 (29)
Transmitted 91 of 101 monitored days
Transmitted 173 of 177 days***

A total of 3 intervention participants did not meet the primary outcome of BP control as described below.

*

Had technical difficulties measuring BP.

**

Was resistant to BP medication addition.

***

Had fluctuating BP and was referred back to primary care for ambulatory monitoring.